ORAGENICS INC (OGEN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150K 300K 450K Q2 '11: 347.6K Q3 '11: 350.4K Q4 '11: 396.6K Q1 '12: 380.5K Q2 '12: 256.4K Q3 '12: 264.2K Q4 '12: 430.6K Q1 '13: 176.4K Q2 '13: 167.7K Q3 '13: 253.4K Q4 '13: 434.8K Q1 '14: 214.7K Q2 '14: 303.8K Q3 '14: 201K Q4 '14: 220.5K Q1 '15: 363.8K Q2 '15: 242K Q2 '15: 242K Q3 '15: 329.8K Q4 '15: 240.2K Q1 '16: 262.3K Q2 '16: 0 Q3 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '22: 15.1K Q2 '22: 30.4K Q3 '22: 86K Q4 '22: 0 Q1 '23: 17K Q2 '23: 13.2K Q3 '23: 7.5K Q4 '23: 0 Q2 '12 Q3 '13 Q4 '14 Q4 '15 Q1 '17 Q2 '18 Q3 '22 Q4 '23

Gross Profit Quarterly

-300K -150K 0 150K 300K 450K Q2 '10: 177.3K Q3 '10: 217.3K Q1 '11: 255K Q2 '11: 18.8K Q3 '11: 215.9K Q1 '12: 182.3K Q2 '12: 144.1K Q3 '12: 100.2K Q4 '12: 26.6K Q1 '13: 112.5K Q2 '13: 81K Q3 '13: 140K Q4 '13: 355.4K Q1 '14: 134.9K Q2 '14: 178.1K Q3 '14: 127.3K Q4 '14: 130K Q1 '15: 195.8K Q2 '15: 155.3K Q2 '15: 0 Q3 '15: 0 Q1 '16: 172.3K Q2 '16: 0 Q3 '16: 0 Q4 '16: -172.3K Q2 '10 Q3 '11 Q4 '12 Q4 '13 Q4 '14 Q3 '15 Q4 '16

Operating Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q4 '16: -2.7M Q1 '17: -2M Q2 '17: -1.4M Q3 '17: -1.9M Q4 '17: -1.4M Q1 '18: -2.1M Q2 '18: -2.3M Q2 '18: -2.3M Q3 '18: -2.8M Q4 '18: -2.8M Q1 '19: -3.4M Q2 '19: -4.9M Q3 '19: -3.9M Q4 '19: -3.7M Q1 '20: -5.2M Q2 '20: -12.4M Q3 '20: -4.5M Q4 '20: -4.5M Q1 '21: -5.2M Q2 '21: -3.8M Q3 '21: -4.4M Q4 '21: -2.3M Q1 '22: -4.6M Q2 '22: -3.6M Q3 '22: -3.9M Q4 '22: -2.3M Q1 '23: -2.9M Q2 '23: -3.1M Q3 '23: -2.1M Q4 '23: -12.8M Q1 '24: -2.5M Q2 '24: -2.3M Q3 '24: -2.4M Q4 '24: -3.4M Q1 '25: -2M Q2 '25: -1.7M Q3 '25: -3.1M Q4 '25: -2.5M Q1 '26: -2.3M Q2 '26: -2.6M Q4 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q4 '16: -2.7M Q1 '17: -2M Q2 '17: -1.2M Q3 '17: -2.1M Q4 '17: -1.5M Q1 '18: -2.1M Q2 '18: -2.3M Q2 '18: -2.3M Q3 '18: -2.8M Q4 '18: -2.8M Q1 '19: -3.3M Q2 '19: -4.8M Q3 '19: -3.8M Q4 '19: -3.6M Q1 '20: -5.2M Q2 '20: -12.3M Q3 '20: -4.5M Q4 '20: -4.4M Q1 '21: -5.2M Q2 '21: -3.8M Q3 '21: -4.4M Q4 '21: -2.3M Q1 '22: -4.6M Q2 '22: -3.6M Q3 '22: -3.9M Q4 '22: -2.2M Q1 '23: -2.8M Q2 '23: -3.1M Q3 '23: -2M Q4 '23: -12.7M Q1 '24: -2.5M Q2 '24: -2.3M Q3 '24: -2.5M Q4 '24: -3.3M Q1 '25: -2.2M Q2 '25: -2.3M Q3 '25: -3.1M Q4 '25: -2.3M Q1 '26: -2.2M Q2 '26: -2.5M Q4 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '16: -1.6M Q4 '16: -2M Q1 '17: -1.9M Q2 '17: -1.8M Q3 '17: -1.3M Q4 '17: -1.4M Q1 '18: -1.4M Q2 '18: -2.3M Q3 '18: -2.5M Q4 '18: -3M Q1 '19: -2.2M Q2 '19: -3.5M Q3 '19: -3.4M Q4 '19: -3.9M Q1 '20: -3.8M Q2 '20: -4.8M Q3 '20: -4.7M Q4 '20: -3.6M Q1 '21: -4.3M Q2 '21: -2.1M Q3 '21: -4.6M Q4 '21: -2.5M Q1 '22: -5.6M Q2 '22: -3.4M Q3 '22: -3.8M Q4 '22: -2.4M Q1 '23: -2.1M Q2 '23: -2.6M Q3 '23: -1.5M Q4 '23: -1.1M Q1 '24: -3.1M Q2 '24: -1.5M Q3 '24: -2M Q4 '24: -2M Q1 '25: -2.1M Q2 '25: -1.3M Q3 '25: -3M Q4 '25: -2.8M Q1 '26: -2.2M Q2 '26: -2.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '10: -1.6M Q3 '13: -2M Q4 '13: -1.2M Q1 '14: -1.6M Q2 '14: -1.7M Q3 '14: -1.1M Q4 '14: -1.3M Q1 '15: -1.4M Q2 '15: -965.3K Q3 '15: -1.3M Q4 '15: -1.7M Q4 '16: -2M Q4 '18: -3M Q3 '19: -3.4M Q4 '19: -4M Q4 '21: -2.5M Q1 '22: -5.7M Q2 '22: -3.4M Q3 '22: -3.8M Q4 '22: -2.4M Q3 '13 Q2 '14 Q1 '15 Q4 '15 Q3 '19 Q1 '22 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '21: 103M Q2 '21: 115.9M Q3 '21: 116.3M Q1 '22: 2M Q2 '22: 1.9M Q3 '22: 1.9M Q1 '23: 2.2M Q2 '23: 2M Q3 '23: 2.4M Q1 '24: 3.5M Q2 '24: 151K Q3 '24: 217.6K Q1 '25: 607.2K Q2 '25: 731.8K Q3 '25: 1.6M Q1 '26: 4.3M Q2 '26: 4.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q1 '16: -0.33 Q2 '16: -0.17 Q3 '16: -0.16 Q4 '16: -1.57 Q1 '17: -1.92 Q2 '17: -2.16 Q3 '17: -2.54 Q4 '17: -1.37 Q1 '18: -1.39 Q2 '18: -1.52 Q1 '19: -0.93 Q2 '19: -0.65 Q3 '19: -0.38 Q4 '19: -0.37 Q1 '20: -0.37 Q2 '20: -0.51 Q3 '20: -0.51 Q4 '20: -0.47 Q1 '21: -0.41 Q2 '21: -0.20 Q3 '21: -0.16 Q4 '21: -0.14 Q1 '22: -2.38 Q2 '22: -4.20 Q3 '22: -6.15 Q4 '22: -7.03 Q1 '23: -6.15 Q2 '23: -5.81 Q3 '23: -4.67 Q4 '23: -9.25 Q1 '24: -8.54 Q2 '24: -22.30 Q3 '24: -32.77 Q4 '24: -47.88 Q1 '25: -50.83 Q2 '25: -38.66 Q3 '25: -29.30 Q4 '25: -4.56 Q1 '26: -1.42 Q2 '26: 1.11 Q1 '17 Q2 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.